Comment on: Jaine et al Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand. Lung Cancer 2018, 124, 233-240. 2018/10/01. DOI: 10.1016/j.lungcan.2018.08.004

Lung Cancer. 2020 Jul:145:219-220. doi: 10.1016/j.lungcan.2020.04.008. Epub 2020 May 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Early Detection of Cancer
  • Humans
  • Lung Neoplasms*
  • Mass Screening
  • New Zealand
  • Tomography, X-Ray Computed